sGCα1 mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handling

被引:28
作者
Cawley, Sharon M. [1 ,2 ]
Kolodziej, Starsha [2 ]
Ichinose, Fumito [2 ]
Brouckaert, Peter [3 ,4 ]
Buys, Emmanuel S. [2 ]
Bloch, Kenneth D. [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Anesthesia Ctr Crit Care Res, Boston, MA 02114 USA
[3] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium
[4] VIB, Dept Mol Biomed Res, Ghent, Belgium
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2011年 / 301卷 / 01期
关键词
cyclic-3; 5 '-guanosine monophosphate; beta(3)-adrenergic receptor; cardiac contractility; nitric oxide; soluble guanylate cyclase; NITRIC-OXIDE SYNTHASE; SOLUBLE GUANYLATE-CYCLASE; CYCLIC-GMP; VENTRICULAR MYOCYTES; PROTEIN-KINASE; CONTRACTILE RESPONSE; HEART-FAILURE; SARCOPLASMIC-RETICULUM; ADRENERGIC-STIMULATION; MYOCARDIAL-INFARCTION;
D O I
10.1152/ajpheart.01273.2010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cawley SM, Kolodziej S, Ichinose F, Brouckaert P, Buys ES, Bloch KD. sGC alpha(1) mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handling. Am J Physiol Heart Circ Physiol 301: H157-H163, 2011. First published May 2, 2011; doi:10.1152/ajpheart.01273.2010.-In the heart, nitric oxide (NO) modulates contractile function; however, the mechanisms responsible for this effect are incompletely understood. NO can elicit effects via a variety of mechanisms including S-nitrosylation and stimulation of cGMP synthesis by soluble guanylate cyclase (sGC). sGC is a heterodimer comprised of a beta(1)- and an alpha(1)- or alpha(2)-subunit. sGC alpha(1)beta(1) is the predominant isoform in the heart. To characterize the role of sGC in the regulation of cardiac contractile function by NO, we compared left ventricular cardiac myocytes (CM) isolated from adult mice deficient in the sGC alpha(1)-subunit (sGC alpha(-/-)(1)) and from wild-type (WT) mice. Sarcomere shortening under basal conditions was less in sGC alpha(-/-)(1) CM than in WT CM. To activate endogenous NO synthesis from NO synthase 3, CM were incubated with the beta(3)-adrenergic receptor (beta(3)-AR) agonist BRL 37344. BRL 37344 decreased cardiac contractility in WT CM but not in sGC alpha(-/-)(1) myocytes. Administration of spermine NONOate, an NO donor compound, did not affect sarcomeric shortening in CM of either genotype; however, in the presence of isoproterenol, addition of spermine NONOate reduced sarcomere shortening in WT but not in sGC alpha(-/-)(1) CM. Neither BRL 37344 nor spermine NONOate altered calcium handling in CM of either genotype. These findings suggest that sGC alpha(1) exerts a positive inotropic effect under basal conditions, as well as mediates the negative inotropic effect of beta(3)-AR signaling. Additionally, our work demonstrates that sGC alpha(1)beta(1) is required for NO to depress beta(1)/beta(2)-AR-stimulated cardiac contractility and that this modulation is independent of changes in calcium handling.
引用
收藏
页码:H157 / H163
页数:7
相关论文
共 51 条
[1]   Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms [J].
Barouch, LA ;
Harrison, RW ;
Skaf, MW ;
Rosas, GO ;
Cappola, TP ;
Kobeissi, ZA ;
Hobai, IA ;
Lemmon, CA ;
Burnett, AL ;
O'Rourke, B ;
Rodriguez, ER ;
Huang, PL ;
Lima, JAC ;
Berkowitz, DE ;
Hare, JM .
NATURE, 2002, 416 (6878) :337-340
[2]   Functional β-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes [J].
Boivin, Benoit ;
Lavoie, Catherine ;
Vaniotis, George ;
Baragli, Alessandra ;
Villeneuve, Louis-Robert ;
Ethier, Nathalie ;
Trieu, Phan ;
Allen, Bruce G. ;
Hebert, Terence E. .
CARDIOVASCULAR RESEARCH, 2006, 71 (01) :69-78
[3]   Sildenafil inhibits β-adrenergic-stimulated cardiac contractility in humans [J].
Borlaug, BA ;
Melenovsky, V ;
Marhin, T ;
Fitzgerald, P ;
Kass, DA .
CIRCULATION, 2005, 112 (17) :2642-2649
[4]   Tissue distribution of the human soluble guanylate cyclases [J].
Budworth, J ;
Meillerais, S ;
Charles, L ;
Powell, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 263 (03) :696-701
[5]   Gender-specific hypertension and responsiveness to nitric oxide in sGCα1 knockout mice [J].
Buys, Emmanuel S. ;
Sips, Patrick ;
Vermeersch, Pieter ;
Raher, Michael J. ;
Rogge, Elke ;
Ichinose, Fumito ;
Dewerchin, Mieke ;
Bloch, Kenneth D. ;
Janssens, Stefan ;
Brouckaert, Peter .
CARDIOVASCULAR RESEARCH, 2008, 79 (01) :179-186
[6]   Modulation of in vivo cardiac function by myocyte-specific nitric oxide synthase-3 [J].
Champion, HC ;
Georgakopoulos, D ;
Takimoto, E ;
Isoda, T ;
Wang, YB ;
Kass, DA .
CIRCULATION RESEARCH, 2004, 94 (05) :657-663
[7]   Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase Iα inhibit NO-induced cerebral dilation [J].
Dostmann, WRG ;
Taylor, MS ;
Nickl, CK ;
Brayden, JE ;
Frank, R ;
Tegge, WJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (26) :14772-14777
[8]   Inhibition of beta- but not alpha(1)-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP [J].
Ebihara, Y ;
Karmazyn, M .
CARDIOVASCULAR RESEARCH, 1996, 32 (03) :622-629
[9]   Cyclic GMP-dependent protein kinases and the cardiovascular system [J].
Feil, R ;
Lohmann, SM ;
de Jonge, H ;
Walter, U ;
Hofmann, F .
CIRCULATION RESEARCH, 2003, 93 (10) :907-916
[10]   MECHANISM OF ACTION OF ACETYLCHOLINE ON CALCIUM CURRENT IN SINGLE CELLS FROM FROG VENTRICLE [J].
FISCHMEISTER, R ;
HARTZELL, HC .
JOURNAL OF PHYSIOLOGY-LONDON, 1986, 376 :183-202